EU Approves First Bronchiolitis Vaccine: A Landmark Achievement

The European Commission announces the marketing of the first vaccine against bronchiolitis, to be administered to pregnant women.

The European Commission announced Friday evening that it authorized the marketing of Abrysvo, the vaccine of the pharmaceutical giant Pfizer against bronchiolitis in infants and people over 60 years of age. The European Medicines Agency had approved it in July.

The vaccine, administered to pregnant women, targets the highly contagious respiratory syncytial virus (RSV), which causes thousands of deaths and hundreds of thousands of hospitalizations worldwide, causing bronchiolitis and pneumonia.

In addition, a preventive treatment jointly developed by AstraZeneca and Sanofi, called Beyfortus and intended for infants, has recently been authorized in Europe and the United States.

This article is originally published on radio1.pf

Electric Scooter XElectric Scooter XElectric Scooter XElectric Scooter X

Subscribe

Related articles

German MEP Markus Buchheit shares pro-Kremlin narratives

MEP Markus Buchheit of Germany belongs to the far-right...

MEP Andor Deli’s Pro-Russian sentiments 

MEP Andor Deli from Hungary is affiliated with the...

Former MEP Lars Patrick Berg’s Nuanced Approach to Russia

Lars Patrick Berg, a former MEP from the ECR...

MEP Edina Tóth’s Votes Reflect Pro-Russian Sympathies

MEP Edina Tóth representing the Fidesz party, has been...

MEP Katarína Roth Neveďalová a Pro-Russia Advocate

MEP Katarína Roth Neveďalová, from Slovakia, has been associated...
Electric Scooter X